Eric Billy - Oncology, Novartis Institutes for Biomedical Research

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 74 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Raising Concerns on Questionable Ethics Approvals – a Case Study of 456 Trials from the Institut Hospitalo-Universitaire Méditerranée Infection

Fabrice Frank,Nans Florens,Gideon Meyerowitz‑katz,Jerome Barriere,Eric Billy,Veronique Saada,Alexander Samuel,Jacques Robert,Lonni Besancon

Research Integrity and Peer Reviewno. 1 (2025): 1-3

Cited2Views0WOSBibtex

Open Letter: Confronting the IHU Scandal – the Need for Deep Reforms and Decisive Action

Damien Barraud,Jérôme Barriere, Lonni Besançon, Dominique Costagliola,Eric Billy,Fabrice FRANK, Anthony Guihur, Mathieu Molimard, Véronique Saada,Alexander Samuel

crossref（2024）

Cited0Views0Bibtex

Scientific Integrity Requires Publishing Rebuttals and Retracting Problematic Papers

Jérôme Barrière,Fabrice Frank,Lonni Besançon,Alexander Samuel,Véronique Saada,Eric Billy,Abraham Al-Ahmad,Barbara Seitz-Polski,Jacques Robert

STEM CELL REVIEWS AND REPORTS（2023）

Cited3Views0WOSBibtex

Supplementary Figure 3 from SHP2 Inhibition Overcomes RTK-Mediated Pathway Reactivation in KRAS-Mutant Tumors Treated with MEK Inhibitors

Hengyu Lu, Chen Liu,Roberto Velazquez,Hongyun Wang,Lukas Manuel Dunkl,Malika Kazic-Legueux,Anne Haberkorn,Eric Billy,Eusebio Manchado,Saskia M. Brachmann,Susan E. Moody,Jeffrey A. Engelman,Peter S. Hammerman,Giordano Caponigro,Morvarid Mohseni,Huai-Xiang Hao

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure 4 from SHP2 Inhibition Overcomes RTK-Mediated Pathway Reactivation in KRAS-Mutant Tumors Treated with MEK Inhibitors

Hengyu Lu,Chen Liu,Roberto Velazquez, Hongyun Wang,Lukas Manuel Dunkl,Malika Kazic-Legueux,Anne Haberkorn,Eric Billy,Eusebio Manchado,Saskia M. Brachmann,Susan E. Moody,Jeffrey A. Engelman,Peter S. Hammerman,Giordano Caponigro,Morvarid Mohseni,Huai-Xiang Hao

openalex（2023）

Cited0Views0Bibtex

Supplementary Table 1 from SHP2 Inhibition Overcomes RTK-Mediated Pathway Reactivation in KRAS-Mutant Tumors Treated with MEK Inhibitors

Hengyu Lu,Chen Liu,Roberto Velazquez,Hongyun Wang,Lukas Manuel Dunkl,Malika Kazic-Legueux,Anne Haberkorn,Eric Billy,Eusebio Manchado,Saskia M. Brachmann,Susan E. Moody,Jeffrey A. Engelman,Peter S. Hammerman,Giordano Caponigro,Morvarid Mohseni,Huai-Xiang Hao

openalex（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn